Newsweek on MSN9h
Nasal Spray Could Delay Alzheimer's by YearsAn anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
Among the latest innovations are tanning nasal sprays and Permatan—two methods that have been generating buzz in the beauty ...
ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...
Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...
A new therapy may delay Alzheimer's disease progression by years, according to a study by researchers at Texas A&M University ...
SoundHealth, Inc. ("SoundHealth"), a medical technology company harnessing the power of artificial intelligence and medical ...
An extensive review determined that the ingredient, oral phenylephrine, doesn’t actually relieve nasal congestion.
Our primary focus at Milestone is preparing for potential FDA approval of CARDAMYST nasal spray for the management of PSVT,” said ...
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
ALK licenses rights to adrenaline nasal spray, neffy from ARS Pharma for emergency treatment of allergic reactions: Hørsholm, Denmark Tuesday, November 12, 2024, 12:00 Hrs [IST] ...
CNET on MSN2d
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine IngredientPhenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback